HomeCompaniesMaven Bio

Maven Bio

Your AI analyst for BioPharma market intelligence

Maven Bio empowers business development teams, consultants, and bankers focused on BioPharma to perform end-to-end analysis workflows typically done by a junior analyst in a fraction of the time. Maven Bio’s AI Analyst can construct a full competitive landscape, research specific drugs or companies, or analyze trial data, all by leveraging our curated content library of over 10 million BioPharma documents. In contrast to general purpose market intel solutions, Maven Bio is designed for the needs of BioPharma, with deep feature sets built around high-leverage industry workflows, all with the goal of empowering teams to understand their market and competitive landscape. Try it now at mavenbio.io

Jobs at Maven Bio

Boston, MA, US
$80K - $120K
1+ years
Maven Bio
Founded:2023
Team Size:5
Location:Boston
Group Partner:Garry Tan

Active Founders

Michael Brady, Founder

Helping BioPharma teams evaluate therapeutic opportunities. Passionate about building AI-native software. Boston native.
Michael Brady
Michael Brady
Maven Bio

Arjun Murthy, Founder

Proactive Biopharma intelligence. Passionate about helping teams in life sciences navigate complexity with the right information at the right time.
Arjun Murthy
Arjun Murthy
Maven Bio

Company Launches

TL;DR: Maven Bio’s AI Analyst can construct a full competitive landscape, research specific drugs or companies, or analyze trial data, all by leveraging our curated content library of over 10 million BioPharma documents. Join hundreds of users from the world's top BioPharma companies, consultancies, and venture capital firms and try our robust free tier at mavenbio.io

🎯 The Problem:

More than 90% of clinical-stage drugs fail - yet while scientific failures get most of the attention, ~20% of all programs actually fail for business and commercial reasons.

Why?

Today, therapeutic opportunities are evaluated using a highly manual process with fragmented information along with a heavy dose of consultants, hundreds of slides, and dozens of disparate data sources, which makes it difficult and time-consuming to assess the commercial potential of a drug.

✨ Our Solution:

Maven Bio’s AI Analyst for BioPharma Market Intelligence empowers teams to get smart on an opportunity area and understand the competitive landscape faster and more effectively.

Unlike a generative chatbot or traditional database that provides rows of data but takes no action, Maven Bio’s AI Research Analyst actually performs analysis for you, giving you meaningful insights on critical BioPharma business questions like:

  • What is the competitive landscape, and how differentiated is a given drug compared to current treatments?
  • What are the different approaches companies are taking to develop drugs for this disease, and how do they compare?
  • How are patients treated today, and what are the gaps in treatment and the level of unmet need?

In a field where accuracy is crucial, we leverage our proprietary content library of over 10 million BioPharma documents with a unique combination of both financial and scientific information, including drug and trial data, press releases, SEC filings, earnings transcripts, and much more to provide unrivaled breadth and depth.

https://youtu.be/eG2awolu3cM

👋 Our ask: How you can help

  • Join hundreds of users across top BioPharma companies and try it yourself at mavenbio.io - we have a robust free tier!
  • Connect us with relevant professionals in BioPharma, including:
    • Consultants focused on the BioPharma space
    • Business development, corporate development, and new product planning roles at BioPharma companies
    • Investment professionals (bankers, VCs, etc.) focused on Biotech

If you want to discuss additional customizations available in our Enterprise plan, or just want to chat, connect with us here.